Effect of Exercise and Pharmacological Interventions on Visceral Adiposity: A Systematic Review and Meta-analysis of Long-term Randomized Controlled Trials
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Objective To assess the effectiveness of exercise and pharmacotherapy interventions in reducing visceral adipose tissue (VAT). Patients and Methods A systematic search of Ovid MEDLINE, Scopus, Web of Science, Cochrane Library, ClinicalTrials.gov, New York Academy of Science Grey Literature Report, and OpenGrey was combined with hand searches of existing literature. A total of 2515 titles and abstracts were reviewed. Only randomized controlled trials evaluating the effectiveness of monitored exercise or pharmacological interventions in reducing VAT by using computed tomography or magnetic resonance imaging during a sustained intervention period (≥6 months) were included. Data were independently extracted by reviewers according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines and assessed for quality and risk of bias. Separate analyses for each intervention were performed using random effect models, with pooled estimates of the change in VAT area (in centimeters squared) from baseline to follow‐up reported as standardized mean difference (SMD; with 95% CI). Results A total of 3602 participants from 17 randomized controlled trials were included in the final analysis. Both exercise and pharmacological interventions were associated with significant reductions in VAT: small reduction with pharmacological interventions (SMD, −0.27; 95% CI, −0.47 to −0.07; P=.02) and more substantial reductions with exercise interventions (SMD, −0.54; 95% CI, −0.63 to −0.46; P<.001). The mean absolute VAT reduction was greater in pharmacological trials than in exercise trials. Meta‐regression exhibited a linear correlation between VAT and weight loss (R2=0.52 for exercise and R2=0.88 for pharmacological interventions), but VAT reduction relative to weight loss differed by intervention type. Conclusion Exercise interventions resulted in greater reduction in VAT relative to weight loss than did pharmacological interventions. A preferential reduction in VAT may be clinically meaningful when monitoring success of interventions because weight loss alone may underestimate benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814 · cited 1×
“T he adverse cardiometabolic effects of obesity are well described, with a growing recognition that visceral adipose tissue (VAT) is a key contributor to the pathogenesis of the metabolic syndrome.(1) Accumulation of VAT is also associated with an increased risk of cardiovascular disease,(2) type 2 diabetes,(3) and ca…”
Body Fat Distribution and Risk of Cardiovascular Disease: An Update
Després, J.-P. (2012) · Circulation · doi:10.1161/circulationaha.111.067264 · Cited by 1,481
Self-citationMetan: fixed- and random-effects meta-analysis
Harris, R. J., Deeks, J. J., Altman, D. G., Bradburn, M. J., Harbord, R. M., & Sterne, J. A. C. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800102 · Cited by 1,027 · cited 1×
“1 (StataCorp LP).(15) The risk of bias analysis was performed using the Cochrane Collaboration’s assessment tool in RevMan version 5.”
Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.179 · Cited by 937
Self-citationon behalf of the NN8022-1807 Investigators, Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E. J., Niskanen, L., Rasmussen, M. F., Rissanen, A., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.158 · Cited by 757
Irwin, M. L., Yasui, Y., Ulrich, C. M., Bowen, D., Rudolph, R. E., Schwartz, R. S., Yukawa, M., Aiello, E., Potter, J. D., & McTiernan, A. (2003) · JAMA · doi:10.1001/jama.289.3.323 · Cited by 517
Gutin, B., Barbeau, P., Owens, S., Lemmon, C. R., Bauman, M., Allison, J., Kang, H.-S., & Litaker, M. S. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.5.818 · Cited by 461
Bays, H. E. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.038 · Cited by 431
Ismail, I., Keating, S. E., Baker, M. K., & Johnson, N. A. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00931.x · Cited by 345
Vissers, D., Hens, W., Taeymans, J., Baeyens, J.-P., Poortmans, J., & Van Gaal, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056415 · Cited by 331
Verheggen, R. J. H. M., Maessen, M. F. H., Green, D. J., Hermus, A. R. M. M., Hopman, M. T. E., & Thijssen, D. H. T. (2016) · Obesity Reviews · doi:10.1111/obr.12406 · Cited by 318
Slentz, C. A., Aiken, L. B., Houmard, J. A., Bales, C. W., Johnson, J. L., Tanner, C. J., Duscha, B. D., & Kraus, W. E. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00124.2005 · Cited by 296
Poehlman, E. T. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2463 · Cited by 151
Brochu, M., Malita, M. F., Messier, V., Doucet, E., Strychar, I., Lavoie, J.-M., Prud'homme, D., & Rabasa-Lhoret, R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2706 · Cited by 142
Exercise Training Prevents Regain of Visceral Fat for 1 Year Following Weight Loss
Hunter, G. R., Brock, D. W., Byrne, N. M., Chandler‐Laney, P. C., Del Corral, P., & Gower, B. A. (2010) · Obesity · doi:10.1038/oby.2009.316 · Cited by 136
Barone, B. B., Wang, N.-Y., Bacher, A. C., & Stewart, K. J. (2009) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.050906 · Cited by 70
Cited by
Obesity and cardiovascular disease: a scientific statement from the American Heart Association
Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000973 · Cited by 3,691
Self-citationNeeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463
“While weight loss with lifestyle modification is desirable, patients and health-care professionals must recognize that improved dietary patterns and regular physical activity improve MetS independent of weight loss 155 .”
Self-citationObesity and the risk of cardiometabolic diseases
Valenzuela, P. L., Carrera-Bastos, P., Castillo-García, A., Lieberman, D. E., Santos-Lozano, A., & Lucia, A. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00847-5 · Cited by 452
Neeland, I. J., Marso, S. P., Ayers, C. R., Lewis, B., Oslica, R., Francis, W., Rodder, S., Pandey, A., & Joshi, P. H. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00179-0 · Cited by 202
Self-citationManagement of Obesity in Cardiovascular Practice
Després, J.-P., Carpentier, A. C., Tchernof, A., Neeland, I. J., & Poirier, P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.035 · Cited by 87
Self-citation
Metadata
- Authors
- Rao, S., Pandey, A., Garg, S., Park, B., Mayo, H., Després, J.-P., Kumbhani, D., de Lemos, J. A., & Neeland, I. J.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 94
- Issue
- 2
- Pages
- 211-224
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2914711689
- Cited by
- 75
- References
- 17
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.